Programma di accelerazione per gli Imprenditori delle Scienze della vita (LEAP)
nQ-Medical, Inc. CEO R. A. Bavasso
Helping your life sciences startup succeed
For life sciences entrepreneurs on a mission to improve health through innovation, McDermott has created the Life Sciences Entrepreneurs Acceleration Program (LEAP). LEAP brings the right combination of people, skills and leadership to bear when you need it, helping aggressively grow your business and master your legal needs.
As an early-stage life sciences company, you face new legal and business challenges daily. We provide high-potential organizations with top-quality legal services during the earliest stages of corporate development, and help ease the cost of these services through engagement incentives in the form of deferred fees, discounts and fixed-fee arrangements.
Candidates for LEAP are sponsored by a McDermott partner and evaluated on the quality of their business plan, the ability of the company to meet well-defined milestones, current levels of investment (or the likelihood of obtaining venture-backed financing), and clearance of a business and legal conflict evaluation.
Jace Biomedical, a start-up company that is developing promising new technology that has demonstrated therapeutic potential for the treatment of Alzheimer’s disease, in the areas of corporate formation, license negotiations and intellectual property
Lipomedix, an emerging company focused on the development of an innovative, safe and effective cancer therapy based on liposome delivery, as patent counsel
Nuviant, a medical device manufacturer focused on the development of implantable therapies for the relief of chronic conditions, in the areas of licensing and intellectual property
Nemucore, a clinical development company dedicated to the development and commercialization of life-saving, personalized and molecularly targeted therapeutics focused on women’s oncology, in the areas of intellectual property and licensing
Protein Dynamic Solutions, a life sciences company that provides state of the art protein characterization, with intellectual property, licensing and collaboration, corporate and tax services
Vasoptic, a medical device company developing a low-cost, mobile technology for early diagnosis and management of diabetic retinopathy, with corporate services